Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Cell Therapy Companies

Cell therapy involves the use of living cells to treat or prevent diseases. These therapies can range from the transplantation of cells to the engineering of cells to enhance their therapeutic properties. As of my last knowledge update in January 2022, several companies are actively involved in cell therapy research, development, and commercialization. 

Cell Therapy Key Companies


Latest Cell Therapy Companies Update


Novartis receives FDA approval for Kymriah, a CAR-T cell therapy for acute lymphoblastic leukemia (ALL), marking a significant milestone in personalized cancer treatment. This approval reinforces the potential of CAR-T therapies for challenging diseases.


BlueRock Therapeutics raises $375 million in funding to advance its stem cell treatment for Parkinson's disease, highlighting the growing investor confidence in cell therapy for neurodegenerative conditions


 


Vertex Pharmaceuticals and CRISPR Therapeutics announce positive Phase 1/2 data for their investigational gene editing therapy for sickle cell disease, demonstrating the therapeutic potential of combining gene editing with cell therapy.


List of Cell Therapy Key Companies in the Market 



  • Kolon TissueGene Inc.

  • AlloSource

  • Holostem Terapie Avanzate S.R.L.

  • AlloSource

  • Holostem Terapie Avanzate S.R.L.

  • Castle Creek Biosciences Inc.

  • Anterogen Co. Ltd

  • Celgene Corporation

  • Tameika Cell Technologies Inc.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.